LY2835219
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for LY2835219, covering 2018-08-02 to 2020-08-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY2835219 in Japanese Participants With Advanced Cancer [Phase 1]